Quality & complianceOfficial

Health Canada recalls two Taro-Candesartan 8 mg lots that may contain esomeprazole capsules

🇨🇦 Health Canada · Mon 16 Nov 2026

A Type II recall covers two lots of candesartan tablets distributed nationally in Canada, which may contain esomeprazole 20 mg capsules.

Health Canada has published a Type II recall for two lots of Taro-Candesartan 8 mg tablets. The notice, last updated on 16 November 2026, says the affected lots may contain Esomeprazole 20 mg capsules. The issue is classed as a product quality problem.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: Health Canada ↗

Article written by VigiEye from the official source (Health Canada). AI-assisted; check the source before acting.